StonvexLoading…
StonvexCore line items from LSF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $36.94M | $13.94M | $49.89M | $36.54M | $23.65M |
Operating Income | Not available | $-3.02M | $-3.41M | $-1.61M | $-617.50K |
Net Income | Not available | $1.75M | $-3.25M | $-1.49M | $-362.18K |
EPS (Diluted) | $-0.05 | $0.11 | $-0.31 | $-0.14 | $-0.05 |
Total Assets | Not available | $74.88M | $19.22M | $18.86M | $20.43M |
Total Liabilities | Not available | $12.02M | $7.76M | $6.05M | $7.05M |
Cash & Equivalents | Not available | $10.25M | $5.11M | $5.08M | $3.93M |
Free Cash Flow OCF − CapEx | Not available | $-3.84M | $-2.86M | Not available | Not available |
Shares Outstanding | Not available | 11.61M | 10.69M | 10.67M | 10.64M |